Viramed Biotech AG
Viramed Biotech AG (Viramed) is a privately held medical device company engaged in the development, manufacturing, marketing and selling of diagnostic test products for the in-vitro diagnostic markets. The product portfolio of the company includes bacterial antigens, enzyme-linked immuno sorbent assay (ELISA) tests, direct fluorescent assay (DFA) tests, indirect immunofluorescent assay (IFA) tests, immunoblot and immunostripes for infectious diseases like stomach cancer, gastritis, lyme disease, glandular fever and syphilis. Viramed also offers microbiological services, protein purification and custom development and production. The company offers its products to hospitals, clinics, surgery centers, physician offices, nursing homes, long-term care facilities, home healthcare, and retail healthcare. In addition, the company offers microbiological services, protein purificationcustom product development services. Further, Viramed offers software solutions and bacteria antigents products. Viramed has strong focus on its research and development activities and has a dedicated department, which focuses on the development of new technologies and products. Viramed is headquartered in Planegg, Germany.